Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,005 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.
Khare S, Williamson S, O'Barr B, Schachter L, Chen A, Hayes-Lattin B, Leonard J, Desai A, Ferreira-Gandolfo P, Christmas K, Lackey D, Maziarz RT, Nemecek ER. Khare S, et al. Among authors: leonard j. Clin Lymphoma Myeloma Leuk. 2024 Sep 27:S2152-2650(24)02355-3. doi: 10.1016/j.clml.2024.09.010. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39426942
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.
Lachowiez C, Cook RJ, Hayes-Lattin B, Maziarz RT, Borate U, Traer E, Leonard J, Newell L, Dao KH, Meyers G. Lachowiez C, et al. Among authors: leonard j. Hematol Oncol Stem Cell Ther. 2019 Jun;12(2):105-109. doi: 10.1016/j.hemonc.2019.01.002. Epub 2019 Mar 2. Hematol Oncol Stem Cell Ther. 2019. PMID: 30836091 Free article. Clinical Trial.
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
Lachowiez CA, Long N, Saultz J, Gandhi A, Newell LF, Hayes-Lattin B, Maziarz RT, Leonard J, Bottomly D, McWeeney S, Dunlap J, Press R, Meyers G, Swords R, Cook RJ, Tyner JW, Druker BJ, Traer E. Lachowiez CA, et al. Among authors: leonard j. Blood Adv. 2023 May 9;7(9):1899-1909. doi: 10.1182/bloodadvances.2022009010. Blood Adv. 2023. PMID: 36441905 Free PMC article.
Chronic GvHD-associated serositis and pericarditis.
Leonard JT, Newell LF, Meyers G, Hayes-Lattin B, Gajewski J, Heitner S, Nonas S, Allen B, Stentz A, Frires R, Maziarz RT, Holtan SG. Leonard JT, et al. Bone Marrow Transplant. 2015 Aug;50(8):1098-104. doi: 10.1038/bmt.2015.105. Epub 2015 May 11. Bone Marrow Transplant. 2015. PMID: 25961774
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Newell LF, Williams T, Liu J, Yu Y, Chen Y, Booth GC, Knight RJ, Goslee KR, Cook RJ, Leonard J, Meyers G, Traer E, Press RD, Fan G, Wang Y, Raess PW, Maziarz RT, Dunlap J. Newell LF, et al. Among authors: leonard j. Transplant Cell Ther. 2021 Aug;27(8):662.e1-662.e9. doi: 10.1016/j.jtct.2021.04.014. Epub 2021 Apr 24. Transplant Cell Ther. 2021. PMID: 33901720 Free article.
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.
Newell LF, Dunlap J, Gatter K, Bagby GC, Press RD, Cook RJ, Fletcher L, Leonard JT, Leong KM, Bubalo JS, Olyaei A, Deloughery TG, Maziarz RT, Maynard E, Orloff SL, Enestvedt CK. Newell LF, et al. Among authors: leonard jt. Am J Transplant. 2021 Dec;21(12):3894-3906. doi: 10.1111/ajt.16635. Epub 2021 Jul 19. Am J Transplant. 2021. PMID: 33961341 Free article.
3,005 results